Taiwan FDA registration 6379e58ecae93b71d49b8fb00445455b
"Mefurster" absorbs polyp-dioxoxone sutures
TW: “美芙絲特”可吸收聚對二氧環已酮縫合線
Taiwan·Risk Class 2·MediFirst Co., Ltd.·Registered May 20, 2013 – May 20, 2018CancelledRegistration details
- Analysis ID
- 6379e58ecae93b71d49b8fb00445455b
- Customs Code
- DHA00602503503
Company information
- Manufacturer
- MediFirst Co., Ltd.
- Manufacturer Country
- Korea, Republic of
- Authorized Representative
- BEAUTYCOM BIOTECHNOLOGY CO., LTD.
Product details
- Intended Use
- For details, it is Chinese approved copy of the imitation order
- Product Type (Level 1)
- I General, Plastic Surgery and Dermatology
- Product Type (Level 2)
- I.4840 Absorbable polydioxanone surgical joint
- Import Information
- import
Dates and status
- Registration Date
- May 20, 2013
- Expiry Date
- May 20, 2018
- Cancellation Date
- May 29, 2015
Cancellation information
- Status
- Logged out
- Reason
- 評估未獲通過
About this record
Access comprehensive regulatory information for "Mefurster" absorbs polyp-dioxoxone sutures in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 6379e58ecae93b71d49b8fb00445455b and manufactured by MediFirst Co., Ltd.. The authorized representative in Taiwan is BEAUTYCOM BIOTECHNOLOGY CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices